Showing results (341-350 of 419) with videos related to
Sort By:
Pageof 42
The Journal of Biological Chemistry|February 18, 1994
Aggregation of the chemokine MIP-1 alpha is a dynamic and reversible phenomenon. Biochemical and biological analysesG J Graham, J MacKenzie, S Lowe, et al.Proceedings of the National Academy of Sciences of the United States of America|February 18, 2017
Distance-dependent gradient in NMDAR-driven spine calcium signals along tapering dendritesAlison S Walker, Guilherme Neves, Federico Grillo, et al.Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS|November 29, 2025
Socioeconomic disparities in access to flap reconstruction after oncologic lower extremity resection: A National Inpatient Sample analysisDylan K Kim, Ying Yu, Paul A Asadourian, et al.The EMBO Journal|December 2, 1996
Uncoupling of stem cell inhibition from monocyte chemoattraction in MIP-1alpha by mutagenesis of the proteoglycan binding siteG J Graham, P C Wilkinson, R J Nibbs, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|June 6, 2007
Assessment of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D3 concentrations in male and female multiple sclerosis patients and control volunteersM S Barnes, M P Bonham, P J Robson, et al.Journal of Clinical Lipidology|July 30, 2013
Age, abdominal obesity, and baseline high-sensitivity C-reactive protein are associated with low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B responses to ezetimibe/simvastatin and atorvastatin in patients with metabolic syndromeJennifer G Robinson, Christie M Ballantyne, Willa A Hsueh, et al.Breast Cancer Research : BCR|September 26, 2013
Phase I trial of the oral PARP inhibitor olaparib in combination with paclitaxel for first- or second-line treatment of patients with metastatic triple-negative breast cancerRebecca A Dent, Geoffrey J Lindeman, Mark Clemons, et al.The American Journal of Cardiology|September 26, 2013
Efficacy and safety of ezetimibe added to atorvastatin versus atorvastatin uptitration or switching to rosuvastatin in patients with primary hypercholesterolemiaHarold E Bays, Maurizio Averna, Claudio Majul, et al.Pain|November 8, 2024
Mechanisms of the Native American pain inequity: predicting chronic pain onset prospectively at 5 years in the Oklahoma Study of Native American Pain RiskJamie L Rhudy, Parker A Kell, Taylor V Brown, et al.The Journal of Antibiotics|October 1, 1996
Harziphilone and fleephilone, two new HIV REV/RRE binding inhibitors produced by Trichoderma harzianumJ Qian-Cutrone, S Huang, L P Chang, et al.Pageof 42